You are here

Article Text

Article menu
Download PDFPDF
Letter
Low-dose naltrexone in the perioperative period

https://doi.org/10.1136/rapm-2024-105831

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    PDF extract preview

    You do not have access to the full text of this article, the first page of the PDF of this article appears above.

    Footnotes

    • X @AntjeBarreveld, @TrentDEmerick

    • Contributors All authors contributed to manuscript preparation. EML is responsible for the overall content as a guarantor.

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Competing interests AMB is an advisor for Lin Health. TE has stock/equity in Vanish Therapeutics. All other authors have no competing interests to disclose.

    • Provenance and peer review Not commissioned; externally peer reviewed.